Lung Diseases  >>  budesonide/formoterol  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
budesonide/formoterol / Generic mfg.
NCT00658255: Relative Bronchodilating Effects of Formoterol When Administered Via Symbicort Pressurized Metered-dose Inhaler (pMDI) or Oxis Turbuhaler

Completed
2
175
US
budesonide/formoterol, Symbicort, formoterol, Oxis Turbuhaler
AstraZeneca
Stable Asthma
 
05/03
NCT00239278: Budesonide / Formoterol in Treatment of Exacerbations of COPD

Completed
2
120
Europe
budesonide/formoterol, 2x 200/6 microgram. 4 times daily, Symbicort, prednisolone, 30 mg once daily and placebo
AstraZeneca
Chronic Obstructive Pulmonary Disease
 
01/05
NCT00989833 / 2009-012805-20: Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients

Completed
2
66
Europe
budesonide, Pulmicort Turbuhaler, terbutaline, Bricanyl Turbuhaler, budesonide/formoterol, Symbicort Turbuhaler
AstraZeneca
Exercise Induced Asthma
07/10
07/10
Alloforb, NCT00624754 / 2007-004484-22: Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCT

Completed
2
32
Europe
Formoterol/Budesonide, lactose
Assistance Publique - Hôpitaux de Paris, AstraZeneca
Obstructive Airway Disease
07/12
07/12
NCT01560689: Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation

Completed
2
32
Europe
Budesonide/formoterol, Symbicort, Placebo
Assistance Publique - Hôpitaux de Paris
Bronchiolitis Obliterans, Allogeneic Stem Cell Transplantation
07/12
07/12

Download Options